Foresite Capital Management II’s Epizyme, Inc EPZM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Sell
-690,002
Closed -$1.73M 2
2021
Q4
$1.73M Sell
690,002
-142,334
-17% -$356K 0.66% 2
2021
Q3
$4.26M Sell
832,336
-167,666
-17% -$859K 1.51% 4
2021
Q2
$8.31M Hold
1,000,002
2.24% 3
2021
Q1
$8.71M Hold
1,000,002
2% 3
2020
Q4
$10.9M Buy
1,000,002
+137,600
+16% +$1.49M 2.87% 2
2020
Q3
$10.3M Hold
862,402
2.24% 2
2020
Q2
$13.9M Buy
862,402
+482,421
+127% +$7.75M 2.72% 2
2020
Q1
$5.89M Sell
379,981
-211,323
-36% -$3.28M 1.38% 2
2019
Q4
$14.5M Sell
591,304
-897,140
-60% -$22.1M 2.4% 4
2019
Q3
$15.4M Hold
1,488,444
3.25% 5
2019
Q2
$18.7M Hold
1,488,444
10.5% 4
2019
Q1
$18.4M Sell
1,488,444
-69,420
-4% -$860K 8.33% 5
2018
Q4
$9.6M Buy
1,557,864
+125,500
+9% +$773K 5.09% 5
2018
Q3
$15.2M Sell
1,432,364
-35,851
-2% -$380K 5.62% 5
2018
Q2
$19.9M Sell
1,468,215
-89,893
-6% -$1.22M 7.01% 5
2018
Q1
$27.7M Hold
1,558,108
9.2% 3
2017
Q4
$19.6M Buy
1,558,108
+15,000
+1% +$188K 6.83% 3
2017
Q3
$29.4M Buy
1,543,108
+58,368
+4% +$1.11M 11.92% 3
2017
Q2
$22.4M Sell
1,484,740
-58,378
-4% -$882K 10.27% 3
2017
Q1
$26.5M Buy
1,543,118
+16,481
+1% +$283K 11.35% 3
2016
Q4
$18.5M Sell
1,526,637
-16,481
-1% -$199K 9.27% 4
2016
Q3
$15.2M Buy
1,543,118
+351,123
+29% +$3.45M 7.25% 5
2016
Q2
$12.2M Hold
1,191,995
8.34% 5
2016
Q1
$14.4M Buy
1,191,995
+32,200
+3% +$390K 7.07% 4
2015
Q4
$18.6M Buy
1,159,795
+150,000
+15% +$2.4M 6.23% 5
2015
Q3
$13M Buy
1,009,795
+111,932
+12% +$1.44M 3.94% 7
2015
Q2
$21.5M Buy
897,863
+143,057
+19% +$3.43M 7.56% 5
2015
Q1
$14.2M Buy
754,806
+553,000
+274% +$10.4M 8.4% 3
2014
Q4
$3.81M Buy
+201,806
New +$3.81M 2.61% 13